FCGR3A and classic Hodgkin lymphoma: Vari et al. [22] showed that cHL patients, of whom the EBV status of their HRS cells was not determined, have decreased frequencies and counts of circulating NK cells together with a decreased ratio of CD56dim CD16+/CD56bright CD16- NK cells compared to controls.